Black Bird Biotech (Black Bird Biotech) Forward Dividend Yield % : 0.00% (As of May. 03, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Black Bird Biotech Forward Dividend Yield %?

As of today (2024-05-03), the Forward Annual Dividend Yield of Black Bird Biotech is 0.00%.

As of today (2024-05-03), the Trailing Annual Dividend Yield of Black Bird Biotech is 0.00%.

BBBT's Forward Dividend Yield % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 1.83
* Ranked among companies with meaningful Forward Dividend Yield % only.

Black Bird Biotech's Dividends per Share for the three months ended in Sep. 2023 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Black Bird Biotech's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Black Bird Biotech's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Black Bird Biotech's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Black Bird Biotech's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Black Bird Biotech's Forward Dividend Yield % falls into.

Black Bird Biotech Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Black Bird Biotech (OTCPK:BBBT) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Black Bird Biotech Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Black Bird Biotech's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Black Bird Biotech (Black Bird Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Black Bird Biotech Inc (OTCPK:BBBT) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

11961 Hilltop Road, Suite 22, Argyle, TX, USA, 76226

Website

https://www.blackbirdpotentials.com

Black Bird Biotech Inc is a licensed grower of industrial hemp under the Montana Hemp Pilot Program. In addition, it is the distributor in the U. S. and Canada for MiteXstream, an EPA-registered plant-based biopesticide effective in the eradication of spider mites, a pest that destroys crops, especially cannabis, hops, coffee, and house plants, as well as molds and mildew. Its products include MiteXstream Biopesticide, Grizzly Creek Naturals, and Black Bird American Hemp.

Executives

Jeffrey A Collins	director, 10 percent owner, officer: President	302 WASHINGTON ST., #513, SAN DIEGO CA 92103
Robert Edward Shea	director, 10 percent owner, officer: President, CEO, CFO, CAO	40 WARREN STREET, 3RD FLOOR, CHARLESTOWN MA 02129
John James Sutherland	director, 10 percent owner, officer: President, CEO, CFO & CAO	C/O SUITE 810 - 675 WEST HASTINGS STREET, VANCOUVER A1 V6B 1N2